A CONTEMPORARY POPULATION-BASED COMPARATIVE ANALYSIS OF OUTCOMES AND COSTS FOLLOWING ROBOTIC AND NON-ROBOTIC RADICAL CYSTECTOMIES IN THE UNITED STATES
COST-EFFECTIVENESS ANALYSIS OF PERCUTANEOUS RENAL MASS BIOPSY TO GUIDE THE MANAGEMENT OF SMALL RENAL MASSES
COS2-1 THE IMPACT OF SURGEON VOLUME ON THE MORBIDITY AND COSTS OF RADICAL CYSTECTOMY IN THE UNITED STATES: A CONTEMPORARY POPULATION-BASED ANALYSIS
COST-EFFECTIVENESS ANALYSIS OF PERCUTANEOUS RENAL MASS BIOPSY TO GUIDE THE MANAGEMENT OF SMALL RENAL MASSES
COS2-1 THE IMPACT OF SURGEON VOLUME ON THE MORBIDITY AND COSTS OF RADICAL CYSTECTOMY IN THE UNITED STATES: A CONTEMPORARY POPULATION-BASED ANALYSIS
BUDGET IMPACT ANALYSIS OF LINEZOLID IN THE TREATMENT OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) CONFIRMED NOSOCOMIAL PNEUMONIA IN CHINA
COS3-4 HEALTHCARE RESOURCE USE AND COSTS ANALYSIS FROM A CHINESE PAYER PERSPECTIVE OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS NOSOCOMIAL PNEUMONIA (MRSA-NP) PATIENTS TREATED WITH LINEZOLID OR VANCOMYCIN, WITH A FOCUS ON PATIENTS DEVELOPING RENAL FAILURE
COS3-4 HEALTHCARE RESOURCE USE AND COSTS ANALYSIS FROM A CHINESE PAYER PERSPECTIVE OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS NOSOCOMIAL PNEUMONIA (MRSA-NP) PATIENTS TREATED WITH LINEZOLID OR VANCOMYCIN, WITH A FOCUS ON PATIENTS DEVELOPING RENAL FAILURE